This inhibitory interaction in class IA PI3Ks is disrupted in human cancers (helical hotspot mutations in PIK3CA) (Samuels et al., 2004) and immune disorders (helical mutations in PIK3CD in APDS1) (Angulo et al., 2013; Lucas et al., 2014). Here, PIK3CD is linked to immune system disorder.